India Glycols (INDIAGLYCO) — Corporate Action

1 Corporate Action 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Akshay Bansal appointed as Additional Director and KMP at Ennature Bio Pharma.

🔄 What Changed
Senior Managerial Personnel transferred to subsidiary; new appointment as KMP.

🔮 What's Next
Appointment term of 5 years until July 30, 2031.

💡 Investor Takeaway
This leadership move strengthens Ennature Bio Pharma's management continuity.

India Glycols announced the transfer of Akshay Bansal, Head of Sales & Marketing for Ennature Biopharma, to become an Additional Director and Key Managerial Personnel at Ennature Bio Pharma Limited, effective July 31, 2026, following regulatory filings and shareholder approval requirements.

2 Corporate Action 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Cessation of Akshay Bansal as Senior Managerial Personnel and appointment as KMP at Ennature Bio Pharma.

🔄 What Changed
Transfer of Akshay Bansal from India Glycols to Ennature Bio Pharma as Senior Managerial Personnel; appointment as Additional Director and KMP at Ennature Bio Pharma.

💡 Investor Takeaway
The leadership change at Ennature Bio Pharma may affect its strategic direction and governance, potentially influencing India Glycols' subsidiary dynamics and shareholder value.

India Glycols announced the cessation of Akshay Bansal as a Senior Managerial Personnel effective July 31, 2026, following his transfer to Ennature Bio Pharma. The filing details regulatory compliance with SEBI Listing Regulations and references Observation Letters from NSE and BSE concerning the Scheme of Arrangement. It also confirms Ennature Bio Pharma's appointment of Bansal as Additional Director and Key Managerial Personnel effective July 31, 2026, with a five-year term until July 30, 2031.

📊 Stock Analysis — INDIAGLYCO ✨ Ask AI About This

About India Glycols Limited (INDIAGLYCO)

Fast Moving Consumer Goods · Beverages · Listed on NSE

Market Cap: ₹6,832.04 Cr P/E: 32.7

View full INDIAGLYCO stock details →

📡 Get AI alerts when INDIAGLYCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDIAGLYCO — Free

💡 Ask AI about this filing

"How does this affect Ennature Bio Pharma's valuation?" "What is the impact on India Glycols' dividend outlook?" "How does this compare to peer leadership changes?"

Ask AI Free →

📊 More INDIAGLYCO filings

See all INDIAGLYCO filings →

🔥 Also filed on 31 July 2026

KUANTUM Kuantum Papers Limited Announcement RAMRAT Ram Ratna Wires Limited Financial Results MARUTI Maruti Suzuki India Limited Financial Results TVVISION TV Vision Limited Announcement MARUTI Maruti Suzuki India Limited Financial Results JLHL Jupiter Life Line Hospitals Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDIAGLYCO files new disclosures

Track INDIAGLYCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.